PRODUCTS
ColoDefense® Multiplex Stool DNA Methylation Test Kit for Colorectal Cancer
This kit detects the presence of multiple DNA methylation biomarkers in a patient’s stool by highly sensitive fluorescent quantitative PCR technique to determine the patient’s risk for colorectal tumor.
- Product Description
-
Product features
- It can be used for early screening of colorectal cancer, auxiliary diagnosis, and prognosis of postoperative recurrence.
- It achieves high sensitivity and specificity through the combination of bioinformatics-based system thermodynamics guided design and simultaneous detection of multiple methylation biomarkers.
- It features non-invasive detection, in-home sampling, and high public acceptance compared with colonoscopy;
- It is easy and fast to operate, with low cost;
- It can detect advanced adenomas and early CRCs better than other commercially available stool based screening products.
- All raw materials are home-made.
Technical performance indicators
Test results of more than 1,000 clinical samples show the following:
- The sensitivities of this kit for the detection of stage I-II colorectal cancer, stage I-IV colorectal cancer and advanced adenomas are 93%, 92% and 67%, respectively.
- And its specificity stands at 92%.
Note: This kit is for research use only, not for clinical diagnosis.

